GATM介导的肌酸合成通过促进肾小管上皮细胞脂噬缓解急性肾损伤
本研究探讨了甘氨酸脒基转移酶(GATM)在急性肾损伤(AKI)中的作用及机制。通过单细胞数据集、AKI小鼠模型和患者活检发现,GATM在肾小管上皮细胞中显著下调,且与肾功能正相关。GATM敲除加重AKI,而过表达则改善损伤并延缓向慢性肾脏病(CKD)进展,机制上GATM通过增强肌酸合成促进脂噬,且其下调由METTL14/YTHDF2介导的m6A甲基化所致。
要点
- GATM在AKI肾小管上皮细胞中下调,与肾功能正相关。
- GATM过表达通过肌酸合成促进脂噬,减轻AKI并延缓CKD进展。
- METTL14/YTHDF2介导的m6A甲基化导致GATM下调,敲低可恢复GATM并缓解肾损伤。
核心结论
- GATM在AKI中可能发挥保护作用,机制涉及通过肌酸合成促进脂噬。
- METTL14/YTHDF2介导的m6A甲基化导致GATM下调,可能促进肾小管损伤。
- METTL14/YTHDF2-GATM轴可能是AKI治疗探索的候选靶点。
研究设计与样本
- 研究评估了GATM在单细胞数据集、AKI小鼠模型和患者活检中的表达。
- 使用GATM敲除和腺相关病毒介导的过表达小鼠评估体内功能,并在HK-2细胞和原代肾小管上皮细胞中进行体外研究。
- 机制研究整合了转录组测序、脂噬和肌酸合成调控实验,并通过m6A dot blot和siRNA敲低探索上游调控。
主要发现
- GATM在AKI模型和患者的肾小管上皮细胞中显著下调,表达与肾功能正相关。
- GATM敲除加重AKI,而过表达改善损伤并减缓向CKD进展。
- GATM过表达通过增强肌酸合成促进脂噬,该效应可被3-甲基腺嘌呤(3-MA)或肌酸合成阻断逆转。
- METTL14/YTHDF2介导的m6A甲基化导致GATM下调,敲低METTL14/YTHDF2可恢复GATM表达并减轻AKI肾损伤。
临床怎么用
- GATM及其上游METTL14/YTHDF2轴可能作为AKI治疗干预的潜在靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid decline in renal function. Accumulating studies demonstrate that injury to renal tubular epithelial cells (RTECs) is central to the onset and progression of AKI, as well as a key driver of the transition from AKI to chronic kidney disease (CKD). Glycine amidinotransferase (GATM) is the rate-limiting enzyme in creatine synthesis, but its role in AKI remains unknown. This study therefore investigates the regulatory role and molecular mechanism of GATM in AKI. METHODS: GATM expression was assessed in single-cell datasets, AKI mouse models, and patient biopsies. GATM-knockout and adeno-associated virus-mediated overexpression mice were used to evaluate its functional role in vivo, alongside in vitro studies in HK-2 cells and primary RTECs. Mechanistic investigations integrated experiments on transcriptomic sequencing, lipophagy, and regulation of creatine synthesis. Upstream regulation was explored via m6A dot blot and siRNA-mediated knockdown, with a focus on the METTL14/YTHDF2-GATM axis. RESULTS: GATM was significantly downregulated in RTECs across AKI models and patients, with expression correlating positively with renal function. GATM knockout exacerbated AKI, whereas overexpression ameliorated injury and attenuated progression to CKD. Mechanistically, GATM overexpression promoted lipophagy via enhanced creatine synthesis, and these effects were reversed by autophagy inhibitor 3-methyladenine (3-MA) or creatine synthesis blockade. Upstream, METTL14/YTHDF2-mediated m6A methylation contributed to GATM downregulation, and their knockdown restored GATM expression and alleviated renal injury in AKI. CONCLUSION: Our findings suggest that GATM may play a protective role in AKI, potentially through promoting lipophagy via creatine synthesis. Its downregulation via METTL14/YTHDF2-mediated m6A methylation may contribute to tubular injury. The METTL14/YTHDF2-GATM axis may represent a promising candidate for further therapeutic exploration in AKI.
引用
- Guan X, Zhu Y, Yu W, et al. GATM-mediated creatine synthesis alleviates acute kidney injury by promoting lipophagy in renal tubular epithelial cells. Nephrol Dial Transplant. 2026. PMID: 42832037. doi:10.1093/ndt/gfag226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。